SEC Form 4 · accession 0001209191-15-066446
Corbus Pharmaceuticals Holdings, Inc. · CRBP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Yuval Cohen
Officer — Chief Executive Officer · Director
Period of report
Aug 17, 2015
Accepted (ET)
Aug 18, 2015 · 9:01 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001595097
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 17, 2015 | P | 1,025 | $1.937 | A | 3,825 | D | |
| Common Stock | Aug 17, 2015 | P | 1,075 | $1.90 | A | 4,900 | D |
Table II — derivative securities
No Table II lines on this filing.